95 related articles for article (PubMed ID: 29879746)
1. Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients.
Schellhaas B; Pfeifer L; Kielisch C; Goertz RS; Neurath MF; Strobel D
Ultraschall Med; 2018 Dec; 39(6):667-674. PubMed ID: 29879746
[TBL] [Abstract][Full Text] [Related]
2. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
[TBL] [Abstract][Full Text] [Related]
3. Performance of current versus modified CEUS LI-RADS in the diagnosis of non-hepatocellular carcinoma malignancies.
Wen R; Huang F; Lin P; Gao R; Pang J; Wu Y; Yin H; Tang Z; Ma Z; He Y; Yang H
Abdom Radiol (NY); 2023 Dec; 48(12):3688-3695. PubMed ID: 37726380
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Fraquelli M; Nadarevic T; Colli A; Manzotti C; Giljaca V; Miletic D; Štimac D; Casazza G
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013483. PubMed ID: 36053210
[TBL] [Abstract][Full Text] [Related]
5. Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma.
Guo D; Wan W; Bai X; Wen R; Peng J; Lin P; Liao W; Huang W; Liu D; Peng Y; Kang T; Yang H; He Y
Abdom Radiol (NY); 2024 May; 49(5):1432-1443. PubMed ID: 38584190
[TBL] [Abstract][Full Text] [Related]
6. Strategy for Accurate Diagnosis by Contrast-Enhanced Ultrasound of Focal Liver Lesions in Patients Not at High Risk for Hepatocellular Carcinoma: A Preliminary Study.
Xian MF; Li W; Lan WT; Zeng D; Xie WX; Lu MD; Huang Y; Wang W
J Ultrasound Med; 2023 Jun; 42(6):1333-1344. PubMed ID: 36534591
[TBL] [Abstract][Full Text] [Related]
7. HCCs lacking arterial phase hyperenhancement (APHE) on contrast-enhanced ultrasound (CEUS) - a diagnostic challenge. Findings from the prospective multicenter DEGUM CEUS HCC trial.
Strobel D; Agaimy A; Jesper D; Zundler S; Schellhaas B
Ultraschall Med; 2023 Dec; 44(6):606-613. PubMed ID: 36781161
[TBL] [Abstract][Full Text] [Related]
8. Quantification of Hepatocellular Carcinoma Vascular Dynamics With Contrast-Enhanced Ultrasound for LI-RADS Implementation.
Krolak C; Dighe M; Clark A; Shumaker M; Yeung R; Barr RG; Kono Y; Averkiou M
Invest Radiol; 2024 Apr; 59(4):337-344. PubMed ID: 37725492
[TBL] [Abstract][Full Text] [Related]
9. Impact of Hepatocellular Carcinoma Tumor Size on Sonazoid Contrast-Enhanced Ultrasound Enhancement Features.
Chen S; Qiu YJ; Zhang Q; Lu XY; Huang YL; Dong Y; Wang WP
Ultrasound Med Biol; 2024 Jan; 50(1):39-46. PubMed ID: 37778901
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis.
Wu Y; Xia C; Chen J; Qin Q; Ye Z; Song B
Abdom Radiol (NY); 2024 Jan; 49(1):34-48. PubMed ID: 37823913
[TBL] [Abstract][Full Text] [Related]
11. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
Eur Radiol; 2023 Nov; ():. PubMed ID: 37989916
[TBL] [Abstract][Full Text] [Related]
12. Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024.
Lyshchik A; Fetzer DT; Kono Y; Wilson SR; Dietrich CF; Clevert DA; Meloni MF; Jang HJ; Kim TK; Lee JM; Minami Y; Kudo M; Piscaglia F
Radiology; 2024 May; 311(2):e232369. PubMed ID: 38805727
[TBL] [Abstract][Full Text] [Related]
13. Unique portal venous phase imaging discordance between CEUS and MRI: a valuable predictor of intrahepatic cholangiocarcinoma?
Wilson SR; Burrowes DP; Merrill C; Caine BA; Gupta S; Burak KW
Abdom Radiol (NY); 2024 Jan; 49(1):11-20. PubMed ID: 37804423
[TBL] [Abstract][Full Text] [Related]
14. Complementary Role of CEUS and CT/MR LI-RADS for Diagnosis of Recurrent HCC.
Cheng MQ; Huang H; Ruan SM; Xu P; Tong WJ; He DN; Huang Y; Lin MX; Lu MD; Kuang M; Wang W; Wu SH; Chen LD
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136289
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Feasibility and Diagnostic Performance of ACR CEUS LI-RADS and a Modified CEUS LI-RADS for HCC in Examinations Using Sonazoid.
Liao W; Que Q; Wen R; Lin P; Chen Y; Pang J; Guo D; Wen D; Yang H; He Y
J Ultrasound Med; 2023 Nov; 42(11):2501-2511. PubMed ID: 37269244
[TBL] [Abstract][Full Text] [Related]
16. Improving detection performance of hepatocellular carcinoma and interobserver agreement for liver imaging reporting and data system on CT using deep learning reconstruction.
Okimoto N; Yasaka K; Kaiume M; Kanemaru N; Suzuki Y; Abe O
Abdom Radiol (NY); 2023 Apr; 48(4):1280-1289. PubMed ID: 36757454
[TBL] [Abstract][Full Text] [Related]
17. Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria.
Kang HJ; Lee JM; Yoon JH; Yoo J; Kim JH; Park J
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330156. PubMed ID: 37991335
[No Abstract] [Full Text] [Related]
18. Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review.
Jeong WK
J Liver Cancer; 2023 Sep; 23(2):272-283. PubMed ID: 37723641
[TBL] [Abstract][Full Text] [Related]
19. The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.
Tang L; Zhang Y; Zhou Q; Hong Q; Wang Z
J Healthc Eng; 2022; 2022():2608633. PubMed ID: 35368955
[TBL] [Abstract][Full Text] [Related]
20. Novel high-resolution contrast agent ultrasound techniques HiFR CEUS and SR CEUS in combination with shear wave elastography, fat assessment and viscosity of liver parenchymal changes and tumors.
Jung EM; Kaiser U; Herr W; Stroszczynski C; Jung F
Clin Hemorheol Microcirc; 2024; 86(3):263-273. PubMed ID: 38489171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
